Na_v1.7 controls action potential threshold and contributes to the rising phase. by Aristos J. Alexandrou (2601481)

ASYN biochemical state. by Diana F. Lázaro (659832)

Effect of BCA mix on body weight (A), adiposity index (B), food intake (C) and water intake (D). by Mohamed Siliman Misha (19232949)

Effect of PI3K/mTOR and/or MEK inhibition on heat stress induced AKT, mTOR and ERK signaling and cytotoxicity in HCC cells. by Scott M. Thompson (231230)

Basal medium with autologous plasma (AP) or autologous platelet lysate (APL) results in loss of cell surface marker phenotype and impaired growth respectively. by Ana Leda F. Longhini (226617)

Effect of BCA blend on glucose and insulin metabolism. by Mohamed Siliman Misha (19232949)

The bioluminescent response for CoCl₂ (a) and ZnSO₄ (b) of pILACoaR_WT and pILACoaR_NiCoZia. by Gábor Patyi (11846776)

Fig 9 - by Maria Alice Miranda Bezerra Medeiros (11752002)

Fig 6 - by Maria Alice Miranda Bezerra Medeiros (11752002)

Fig 8 - by Maria Alice Miranda Bezerra Medeiros (11752002)

Fig 10 - by Maria Alice Miranda Bezerra Medeiros (11752002)

Variable importance in Random Forest model of seasonal sediment transport with 1468 observations from 2009 to 2018. by Andrew Kulmatiski (833256)

Table5_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.docx by Jiao Wang (47178)

“…All data were analyzed using RevMan 5.3 software. The Cochrane and SYRCLE’s risk-of-bias tools were used to assess the quality of all studies.…”

Table5_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.docx by Jiao Wang (47178)

“…All data were analyzed using RevMan 5.3 software. The Cochrane and SYRCLE’s risk-of-bias tools were used to assess the quality of all studies.…”

Figure 5 from Nuclear Focal Adhesion Kinase Protects against Cisplatin Stress in Ovarian Carcinoma by Yichi Zhang (20458547)

“…<b>H,</b> Image quantitation of pERK to total ERK ratio from samples in <b>G</b>. Values are means ± SD (<i>n</i> = 5 experimental points, **, <i>P</i> < 0.01). …”

Efficacy and Safety of Anti-Interleukin-5 Therapy in Patients with Asthma: A Systematic Review and Meta-Analysis by Fa-Ping Wang (3358667)

“…Pooled analysis revealed significant improvements in FEV₁ (first second forced expiratory volume) (MD = 0.09, 95% CI: 0.06–0.12, <i>I</i>^<i>2</i> = 10%), FEV₁% (MD = 3.75, 95% CI: 1.66–5.83, <i>I</i>^<i>2</i> = 19%), Asthma Quality of Life Questionnaire (AQLQ) score (MD = 0.22, 95% CI: 0.15–0.30, <i>I</i>^<i>2</i> = 0%), decreased blood, sputum eosinophils and asthmatic exacerbation (RR = 0.66, 95% CI: 0.59–0.73, <i>I</i>^<i>2</i> = 51%); peak expiratory flow (PEF) (MD = 5.45, 95% CI: -2.83–13.72, <i>I</i>^<i>2</i> = 0%), histamine PC₂₀ (MD = -0.62, 95% CI: -1.92–0.68, <i>I</i>^<i>2</i> = 0%) or SABA rescue use (MD = -0.11, 95% CI: -0.3–0.07, <i>I</i>^<i>2</i> = 30%) were unaffected; adverse events were not increased (RR = 0.93, 95% CI: 0.89–0.98, <i>I</i>^<i>2</i> = 46%). …”

Fig 7 - by Maria Alice Miranda Bezerra Medeiros (11752002)

Data Sheet 7_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Data Sheet 6_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Data Sheet 1_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”